Helicobacter pylori infection in migraine headache: a true association or an innocent bystander?

Amr Hassan1, Dina Mehany2, Hadeel Gamal Eldin3

  • 1Neurology Department, Cairo University, Cairo, Egypt.

Insights

Helicobacter pylori infection and related gastrointestinal symptoms are more common in migraine patients. However, these factors do not appear to influence migraine frequency or severity.

Area of Science:

  • Gastroenterology and Neurology
  • Microbiology

Background:

  • The relationship between Helicobacter pylori (H. pylori) infection and migraine remains debated, with conflicting research findings.
  • Gastrointestinal (GIT) symptoms are frequently reported by migraine sufferers, prompting investigation into potential links.

Purpose of the Study:

  • To investigate the association between H. pylori infection, GIT symptoms, and migraine.
  • To determine the impact of H. pylori infection and GIT symptoms on migraine frequency and severity.

Main Methods:

  • A case-control study involving 77 migraine patients and 77 healthy controls.
  • H. pylori detection in stool samples; assessment of GIT symptoms (dyspepsia, flatulence, epigastric pain).
  • Migraine severity evaluated using MIDAS and VAS; frequency recorded monthly.

Main Results:

  • H. pylori infection prevalence was significantly higher in migraine patients (77.9%) compared to controls (50.6%).
  • Migraine patients exhibited a significantly higher prevalence of dyspepsia, flatulence, and epigastric pain.
  • Neither H. pylori infection nor GIT symptoms showed a significant effect on migraine attack frequency, MIDAS, or VAS scores.

Conclusions:

  • H. pylori infection and GIT symptoms are more prevalent in individuals with migraine.
  • Current evidence suggests that H. pylori infection and associated GIT symptoms may not directly influence the frequency or severity of migraine attacks.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
601
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
764
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
318
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
665
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
220
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
637